Previous Close | 186.82 |
Open | 186.70 |
Bid | 190.12 x N/A |
Ask | 191.64 x N/A |
Day's Range | 184.80 - 190.44 |
52 Week Range | 184.80 - 251.30 |
Volume | |
Avg. Volume | 203 |
Market Cap | 36.286B |
Beta (5Y Monthly) | 1.46 |
PE Ratio (TTM) | 35.77 |
EPS (TTM) | 5.32 |
Earnings Date | Jul 25, 2022 - Jul 29, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 279.06 |
IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
Mastercard's (MA) first-quarter results reflect improved GDV and switched transactions, partly offset by higher operating expenses.
At this time, I would like to welcome everyone to the IQVIA first quarter 2022 earnings conference call. With me today are Ari Bousbib, chairman and chief executive officer; Ron Bruehlman, executive vice president and chief financial officer; Eric Sherbet, executive vice president and general counsel; Mike Fedock, senior vice president, financial planning and analysis; and Bryan Stengel, associate director, investor relations.